These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7964953)

  • 1. The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group.
    Castleberry RP; Shuster JJ; Smith EI
    J Clin Oncol; 1994 Nov; 12(11):2378-81. PubMed ID: 7964953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems.
    Haase GM; Atkinson JB; Stram DO; Lukens JN; Matthay KK
    J Pediatr Surg; 1995 Feb; 30(2):289-94; discussion 295. PubMed ID: 7738753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infants with neuroblastoma and regional lymph node metastases have a favorable outlook after limited postoperative chemotherapy: a Pediatric Oncology Group study.
    Castleberry RP; Shuster JJ; Altshuler G; Smith EI; Nitschke R; Winick N; McWilliams N; Joshi V; Hayes FA
    J Clin Oncol; 1992 Aug; 10(8):1299-304. PubMed ID: 1634920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review.
    Kushner BH; Cheung NK; LaQuaglia MP; Ambros PF; Ambros IM; Bonilla MA; Ladanyi M; Gerald WL
    J Clin Oncol; 1996 Jul; 14(7):2174-80. PubMed ID: 8683252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma.
    Castleberry RP; Kun LE; Shuster JJ; Altshuler G; Smith IE; Nitschke R; Wharam M; McWilliams N; Joshi V; Hayes FA
    J Clin Oncol; 1991 May; 9(5):789-95. PubMed ID: 2016621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
    Katzenstein HM; Bowman LC; Brodeur GM; Thorner PS; Joshi VV; Smith EI; Look AT; Rowe ST; Nash MB; Holbrook T; Alvarado C; Rao PV; Castleberry RP; Cohn SL
    J Clin Oncol; 1998 Jun; 16(6):2007-17. PubMed ID: 9626197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.
    Navarro S; Amann G; Beiske K; Cullinane CJ; d'Amore ES; Gambini C; Mosseri V; De Bernardi B; Michon J; Peuchmaur M;
    J Clin Oncol; 2006 Feb; 24(4):695-9. PubMed ID: 16446343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study.
    Nitschke R; Smith EI; Altshuler G; Altmiller D; Shuster J; Green A; Castleberry R; Hayes FA; Golembe B; Ducos R
    J Clin Oncol; 1991 Jul; 9(7):1181-8. PubMed ID: 2045858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
    Schneiderman J; London WB; Brodeur GM; Castleberry RP; Look AT; Cohn SL
    J Clin Oncol; 2008 Feb; 26(6):913-8. PubMed ID: 18281664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group.
    Evans AE; D'Angio GJ; Sather HN; de Lorimier AA; Dalton A; Ungerleider RS; Finklestein JZ; Hammond GD
    J Clin Oncol; 1990 Apr; 8(4):678-88. PubMed ID: 2313336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.
    Meany HJ; London WB; Ambros PF; Matthay KK; Monclair T; Simon T; Garaventa A; Berthold F; Nakagawara A; Cohn SL; Pearson AD; Park JR
    Pediatr Blood Cancer; 2014 Nov; 61(11):1932-9. PubMed ID: 25044743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node sampling in localized neuroblastoma: a Pediatric Oncology Group study.
    Contador MP; Johnston S; Smith EI; Shuster JJ; Hayes FA; Castleberry RP
    J Pediatr Surg; 1999 Jun; 34(6):967-74. PubMed ID: 10392915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
    Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
    Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.
    Kushner BH; Cheung NK; LaQuaglia MP; Ambros PF; Ambros IM; Bonilla MA; Gerald WL; Ladanyi M; Gilbert F; Rosenfield NS; Yeh SD
    J Clin Oncol; 1996 Feb; 14(2):373-81. PubMed ID: 8636746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
    Matthay KK; Perez C; Seeger RC; Brodeur GM; Shimada H; Atkinson JB; Black CT; Gerbing R; Haase GM; Stram DO; Swift P; Lukens JN
    J Clin Oncol; 1998 Apr; 16(4):1256-64. PubMed ID: 9552023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting.
    Castel V; García-Miguel P; Cañete A; Melero C; Navajas A; Ruíz-Jiménez JI; Navarro S; Badal MD
    Eur J Cancer; 1999 Apr; 35(4):606-11. PubMed ID: 10492635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A surgical perspective on the current staging in neuroblastoma--the International Neuroblastoma Staging System proposal.
    Smith EI; Haase GM; Seeger RC; Brodeur GM
    J Pediatr Surg; 1989 Apr; 24(4):386-90. PubMed ID: 2732883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial.
    Simon T; Hero B; Benz-Bohm G; von Schweinitz D; Berthold F
    Pediatr Blood Cancer; 2008 May; 50(5):965-9. PubMed ID: 17914735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.